🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
146.94
+1.17 (0.80%)
Nov 20, 2026, 11:55 AM EST - Market open

Palvella Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-74.99-41.72-17.4318.69-27.55
Stock-Based Compensation
16.036.40.830.60.43
Other Operating Activities
10.876.495.96-29.8510.66
Change in Accounts Receivable
0.030.39---
Change in Accounts Payable
1.651.262.24-2.251.98
Change in Other Net Operating Assets
3.872.17-2.43-0.9-0.36
Operating Cash Flow
-43.06-25.01-10.84-13.7-14.84
Operating Cash Flow Growth
-----

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Long-Term Debt Issued
--18.435-
Net Debt Issued (Repaid)
--18.435-
Issuance of Common Stock
232.790.7660-0.03
Other Financing Activities
-16.38-1.428.66--
Financing Cash Flow
216.41-0.6687.0959.57

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Foreign Exchange Rate Adjustments
-0.720.050--
Net Cash Flow
129.73-25.6276.25-8.7-5.27

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Levered Free Cash Flow
-27.99-18.63-5.43-9.96-
Unlevered Free Cash Flow
-22.43-14.99-2.74-9.96-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Change in Working Capital
5.553.82-0.19-3.151.62
SEC Filings: 10-K · 10-Q